comparemela.com
Home
Live Updates
High Impact Chronic Pain Among Adults - Breaking News
Pages:
4
5
6
7
8
9
10
Latest Breaking News On - High impact chronic pain among adults - Page 3 : comparemela.com
South Rampart Pharma Issued Composition of Matter Patent for Novel Non-Toxic Treatment for Pain
- New patent grant further secures South Rampart s competitive position in next-generation and disruptive investigational drugs for acute pain -NE.
United states
Williamk schmidt
Gideon broshy
Maxim jacobs
Hernan bazan
Neuroscience center
Louisiana state university health sciences center
Small business innovation research
America seed fund
National academy of sciences
Health care professionals
Research development funding
Quotient sciences in miami
National institute of neurological disorders
South rampart
Rampart pharma
South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant
South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant - read this article along with other careers information, tips and advice on BioSpace
United states
Williamk schmidt
Gideon broshy
Maxim jacobs
Hernan bazan
Neuroscience center
Louisiana state university health sciences center
Small business innovation research
National institutes of health
America seed fund
National academy of sciences
Health care professionals
Research development funding
Small business technology transfer
Quotient sciences in miami
National institute of neurological disorders
South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant
/PRNewswire/ South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the.
United states
Williamk schmidt
Gideon broshy
Maxim jacobs
Hernan bazan
Neuroscience center
Louisiana state university health sciences center
Small business innovation research
National institutes of health
America seed fund
National academy of sciences
Health care professionals
Research development funding
Small business technology transfer
Quotient sciences in miami
National institute of neurological disorders
South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022 World Congress on Pain
NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ South Rampart Pharma ( South Rampart or the Company ), a clinical-stage life science company advancin.
United states
Williamk schmidt
Gideon broshy
Maxim jacobs
Hernan bazan
Neuroscience center
International association for the study of pain
Louisiana state university health sciences center
Small business innovation research
World congress on pain
America seed fund
National academy of sciences
Health care professionals
Research development funding
Quotient sciences in miami
National institute of neurological disorders
South Rampart Pharma Announces Appointment of Josh Blacher as Chief Financial Officer
NEW ORLEANS, Aug. 16, 2022 /PRNewswire/ South Rampart Pharma ( South Rampart or the Company ), a clinical-stage life science company advancin.
United states
Josh blacher
Williamk schmidt
Gideon broshy
Maxim jacobs
Hernan bazan
Morgan stanley
Small business innovation research
Lehman brothers
National academy of sciences
Health care professionals
Research development funding
Quotient sciences in miami
National institute of neurological disorders
Inmed pharmaceuticals
Neuroscience center
vimarsana © 2020. All Rights Reserved.